Christian Schwentner

Hoppe Seyler Street 3
Tuebingen, BW 72076, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 130 publications

A simple scoring system for predicting inguinal lymph node involvement and survival in patients with penile squamous cell carcinoma.

A simple scoring system for predicting inguinal lymph node involvement and survival in patients with penile squamous cell carcinoma.

Journal: Urologic oncology

Published: September 29, 2025

The 90-day mortality and morbidity after open vs. robot-assisted radical cystectomy with intracorporeal urinary diversion for nonmetastatic bladder cancer : Summary of the iROC study

The 90-day mortality and morbidity after open vs. robot-assisted radical cystectomy with intracorporeal urinary diversion for nonmetastatic bladder cancer : Summary of the iROC study

Journal: Urologie (Heidelberg, Germany)

Published: September 29, 2022

Lessons learned after one year of COVID-19 from a urologist and radiotherapist view: A German survey on prostate cancer diagnosis and treatment.

Lessons learned after one year of COVID-19 from a urologist and radiotherapist view: A German survey on prostate cancer diagnosis and treatment.

Journal: PloS one

Published: October 10, 2021

Recent developments in the treatment of metastatic hormone-sensitive prostate cancer (mHSPC)

Recent developments in the treatment of metastatic hormone-sensitive prostate cancer (mHSPC)

Journal: Aktuelle Urologie

Published: May 18, 2021

Apalutamide in patients with high-risk M0CRPC: data from the pivotal SPARTAN study and initial experience from a compassionate use program

Apalutamide in patients with high-risk M0CRPC: data from the pivotal SPARTAN study and initial experience from a compassionate use program

Journal: Aktuelle Urologie

Published: March 19, 2021

Apalutamide in patients with high-risk M0CRPC: data from the pivotal SPARTAN study and initial experience from a compassionate use program

Apalutamide in patients with high-risk M0CRPC: data from the pivotal SPARTAN study and initial experience from a compassionate use program

Journal: Aktuelle Urologie

Published: February 23, 2021

Receptor Activator of NF Kappa B (RANK) Expression Indicates Favorable Prognosis in Patients with Muscle-invasive Bladder Cancer.

Receptor Activator of NF Kappa B (RANK) Expression Indicates Favorable Prognosis in Patients with Muscle-invasive Bladder Cancer.

Journal: European urology focus

Published: February 02, 2021

Early urinary continence recovery following retzius-sparing robotic-assistant radical prostatectomy with suprapubic catheter: a short-term follow-up outcome.

Early urinary continence recovery following retzius-sparing robotic-assistant radical prostatectomy with suprapubic catheter: a short-term follow-up outcome.

Journal: World journal of urology

Published: January 03, 2021

Advanced prostate cancer: sequence of androgen receptor-targeted substances and chemotherapy determines long-term survival

Advanced prostate cancer: sequence of androgen receptor-targeted substances and chemotherapy determines long-term survival

Journal: Der Urologe. Ausg. A

Published: November 19, 2020

Morbidity and mortality after robot-assisted radical cystectomy with intracorporeal urinary diversion in octogenarians: results from the European Association of Urology Robotic Urology Section Scientific Working Group.

Morbidity and mortality after robot-assisted radical cystectomy with intracorporeal urinary diversion in octogenarians: results from the European Association of Urology Robotic Urology Section Scientific Working Group.

Journal: BJU international

Published: October 15, 2020

PROPOSe: A Real-life Prospective Study of Proclarix, a Novel Blood-based Test to Support Challenging Biopsy Decision-making in Prostate Cancer.

PROPOSe: A Real-life Prospective Study of Proclarix, a Novel Blood-based Test to Support Challenging Biopsy Decision-making in Prostate Cancer.

Journal: European urology oncology

Published: October 01, 2020

Oncological validation of bone turnover markers c-terminal telopeptide of type I collagen (1CTP) and peptides n-terminal propeptide of type I procollagen (P1NP) in patients with prostate cancer and bone metastases.

Oncological validation of bone turnover markers c-terminal telopeptide of type I collagen (1CTP) and peptides n-terminal propeptide of type I procollagen (P1NP) in patients with prostate cancer and bone metastases.

Journal: Translational andrology and urology

Published: July 27, 2020

Showing 1-12 of 130

Last Updated: 09/26/2026